Summary of Dopharma’s webinar about bromhexine

Bromhexine: prophylaxis, supportive therapy or alternative for antimicrobial treatment?

On the 4th of November 2021 Dopharma organized a webinar on the use of bromhexine in livestock. This webinar was introduced by Chris Cornelis, Technical Support veterinarian at Dopharma. She spoke about the year-long successful use of bromhexine in calves. The three different ways to use bromhexine in calves were clearly explained. With this she answered the question which was also the title of this webinar.

The second speaker was prof. em. Dr Johanna Fink-Gremmels. In her lecture: ‘Bromhexine for all animal species: revisiting an old drug’ she explained extensively about the mode of action of bromhexine and its applications in the various animal species. When discussing the mechanism of action, the importance of the mucociliary apparatus as the first line of defense in respiratory infections became clear. The main effect of bromhexine is the support and repair of this mucociliary apparatus. Bromhexine therefore has an important role as adjunctive therapy in respiratory diseases. In addition, some other properties of the molecule were discussed. Very interesting was the explanation of the influence of bromhexine on the concentration of antibiotics in the respiratory tract and the explanation of the role of bromhexine in viral infections such as Corona and Influenza.

Finally, there was an extensive Q&A session that was led in the right direction by moderator Bert Cornelis. Many and diverse questions about different animal species were discussed, which indicates that the webinar was followed with great interest by the participants.

All in all, it was a very successful webinar with about 130 participants from various European countries where Dopharma has registered the product Dophexine 20 mg/g for the treatment of calves, pigs, chickens, turkeys and ducks.